Dr. Nathan Price is CEO of Onegevity, a division of Thorne HealthTech. In 2019, he was named as one of the 10 Emerging Leaders in Health and Medicine by the U.S. National Academy of Medicine, and in 2021 he was appointed to the Board on Life Sciences of the National Academies of Sciences, Engineering, and Medicine.  He is also a (by courtesy) Professor at the Institute for Systems Biology, co-director with biotechnology pioneer Lee Hood of the Hood-Price Lab for Systems Biomedicine, and Affiliate Faculty at the University of Washington in Bioengineering, Computer Science & Engineering, and Molecular & Cellular Biology. He is a Camille Dreyfus Teacher-Scholar, received the 2016 Grace A. Goldsmith award for his work pioneering ‘scientific wellness’, and received a Healthy Longevity Catalyst Award from the National Academy of Medicine in 2020. His has co-authored more than 180 peer-reviewed scientific publications and given over 200 invited talks and keynotes.  He was previously co-founder of Arivale, a pioneering scientific wellness company.  He is a Fellow of the American Institute for Medical and Biological Engineering, a Fellow of the European Society of Preventive Medicine, and has served as a Trustee of the Health and Environmental Sciences Institute and on the Board of Advisors for the American Cancer Society. He also served as Chair of the NIH Study Section on Modeling and Analysis of Biological Systems (MABS) from 2018-2020.